Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 04 March, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Metropolis Healthcare Ltd

About the Company - Metropolis Healthcare Ltd

Metropolis Healthcare Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100MH2000PLC192798 and registration number is 192798. Currently Company is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 1117.13 Cr. and Equity Capital is Rs. 10.23 Cr. for the Year ended 31/03/2022.
Hospitals & Medical ServicesNo.250, D Udyog Bhavan, Mumbai Maharashtra
NamePosition Held
Dr. Sushil Kanubhai ShahChairman & Executive Director
Mrs. Ameera Sushil ShahManaging Director
Mr. Hemant SachdevNon Exe.Non Ind.Director
Mr. Vivek GambhirInd. Non-Executive Director
Mr. Sanjay BhatnagarInd. Non-Executive Director
Mr. Milind Shripad SarwateInd. Non-Executive Director
Ms. Anita RamachandranInd. Non-Executive Director

Metropolis Healthcare Ltd. Share Price Update

Share PriceValue
Previous Day₹1,640.65

Basic Stock Data of Metropolis Healthcare Ltd

Market Cap 8,729 Cr.
Current Price 1,704
High / Low1,831/1,171
Stock P/E70.0
Book Value 204
Dividend Yield0.48 %
ROCE17.4 %
ROE15.2 %
Face Value 2.00

Data Source:

Competitors of Metropolis Healthcare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Narayana Hrudayalaya Ltd 26,710 Cr. 1,3071,445/72334.6 1220.19 %31.6 %33.1 % 10.0
Aashka Hospitals Ltd 195 Cr. 83.285.0/41.4 40.30.00 %0.42 %2.70 % 10.0
Max India Ltd 910 Cr. 211234/76.0 1230.00 %0.53 %1.81 % 10.0
Thyrocare Technologies Ltd 3,515 Cr. 664723/41556.9 89.22.71 %15.3 %10.6 % 10.0
Sakar Healthcare Ltd 820 Cr. 377479/19165.7 1090.00 %8.91 %8.49 % 10.0
Industry Average6,430.00 Cr528.4431.4496.700.58%11.35%11.34%10.00

Metropolis Healthcare Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit918796102907575687970706375
OPM %32%32%33%31%30%26%24%24%26%25%25%23%24%
Other Income34220636347131
Profit before tax817882103785656435548423948
Tax %26%25%25%27%25%27%29%22%26%25%20%26%26%
Net Profit61596175584140344036332936
EPS in Rs11.8411.4612.0014.6511.398.027.816.537.886.996.515.626.92

Metropolis Healthcare Ltd Quarterly Chart

Metropolis Healthcare Ltd Profit & Loss

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit104117116140181203237290348293279
OPM %27%26%24%26%28%27%28%29%28%26%24%
Other Income107293968-1712341512
Profit before tax95101128160164187169244293188177
Tax %34%33%36%33%32%34%24%25%27%24%
Net Profit636882107112124128183215143134
EPS in Rs57.3461.8280.47106.52109.2323.9425.1535.8241.8527.9026.04
Dividend Payout %2%0%100%49%0%55%32%22%19%29%

Metropolis Healthcare Ltd Profit & Loss Yearly Chart

Metropolis Healthcare Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:12%
3 Years:10%
Compounded Profit Growth
10 Years:%
5 Years:7%
3 Years:0%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-6%
1 Year:21%
Return on Equity
10 Years:%
5 Years:24%
3 Years:22%
Last Year:15%

Metropolis Healthcare Ltd Balance Sheet

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital1010101010101010101010
Other Liabilities6987107188110113160181256240232
Total Liabilities3914623915125265507501,0001,5211,4951,509
Fixed Assets1491531422022072132963431,0591,1211,148
Other Assets109141147167216298437647440340323
Total Assets3914623915125265507501,0001,5211,4951,509

Metropolis Healthcare Ltd Reserves and Borrowings Chart

Metropolis Healthcare Ltd Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 77699110210490215249253247
Cash from Investing Activity -61-5696-86136-10463-73648
Cash from Financing Activity -14-9-174-17-87-118-55-33163-292
Net Cash Flow2414-118856279-3213

Metropolis Healthcare Ltd Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days47575454576655454039
Inventory Days47524638535544596864
Days Payable759296978890152160136136
Cash Conversion Cycle19173-52130-54-56-29-33
Working Capital Days22328-2728421141414
ROCE %28%34%46%43%43%40%36%29%17%

Metropolis Healthcare Ltd Financial Efficiency Indicators Chart

Metropolis Healthcare Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders30,67933,52743,55264,16879,89586,40490,09091,45284,26989,69286,24979,878

Metropolis Healthcare Ltd Shareholding Pattern Chart

No. of Metropolis Healthcare Ltd Shareholders

Metropolis Healthcare Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Nippon India Small Cap Fund10854110.45184.86
UTI Flexi Cap Fund8042300.54136.97
Franklin India Smaller Companies Fund7154591.13121.85
UTI Large Cap Fund6175180.9105.17
UTI Value Fund5500001.1793.67
Aditya Birla Sun Life Flexi Cap Fund5060150.4886.18
UTI Mid Cap Fund4188970.7671.34
Quant Small Cap Fund3596680.5561.26
UTI ELSS Tax Saver Fund2374421.2240.44
UTI Small Cap Fund2188381.0837.27

Metropolis Healthcare Ltd ROCE Trend

Metropolis Healthcare Ltd EPS Trend

Metropolis Healthcare Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)27.9141.8735.9725.3624.06
Diluted EPS (Rs.)27.9141.6635.7925.2524.02
Cash EPS (Rs.)45.4254.3144.8633.0528.92
Book Value[Excl.RevalReserv]/Share (Rs.)193.46173.56138.52103.7283.69
Book Value[Incl.RevalReserv]/Share (Rs.)193.46173.56138.52103.7283.69
Revenue From Operations / Share (Rs.)224.21240.04195.24169.15151.69
PBDIT / Share (Rs.)59.2770.4358.3147.6841.57
PBIT / Share (Rs.)41.8558.0849.3239.9237.57
PBT / Share (Rs.)36.6157.3347.8033.4337.46
Net Profit / Share (Rs.)28.0041.9535.8725.3024.92
NP After MI And SOA / Share (Rs.)27.9041.8635.8225.1523.94
PBDIT Margin (%)26.4329.3429.8628.1827.40
PBIT Margin (%)18.6624.1925.2623.6024.76
PBT Margin (%)16.3323.8824.4819.7624.69
Net Profit Margin (%)12.4817.4718.3714.9516.42
NP After MI And SOA Margin (%)12.4417.4318.3414.8615.78
Return on Networth / Equity (%)14.4524.1125.9124.3228.70
Return on Capital Employeed (%)17.3224.1831.4934.6844.02
Return On Assets (%)9.5113.9918.2216.9221.74
Long Term Debt / Equity (X)
Total Debt / Equity (X)
Asset Turnover Ratio (%)0.710.950.961.071.10
Current Ratio (X)1.141.302.982.342.45
Quick Ratio (X)0.971.132.782.202.24
Dividend Payout Ratio (NP) (%)28.6719.1122.3331.5255.37
Dividend Payout Ratio (CP) (%)17.6514.7517.8524.0947.45
Earning Retention Ratio (%)71.3380.8977.6768.4844.63
Cash Earning Retention Ratio (%)82.3585.2582.1575.9152.55
Interest Coverage Ratio (X)11.3218.2638.3028.93392.73
Interest Coverage Ratio (Post Tax) (X)6.3511.0724.5619.29236.44
Enterprise Value (Cr.)6384.2710513.8111037.236303.530.00
EV / Net Operating Revenue (X)5.568.5611.067.360.00
EV / EBITDA (X)21.0329.1737.0326.110.00
MarketCap / Net Operating Revenue (X)5.578.4811.487.600.00
Retention Ratios (%)71.3280.8877.6668.4744.62
Price / BV (X)6.4711.7316.2112.440.00
Price / Net Operating Revenue (X)5.578.4811.487.600.00

Metropolis Healthcare Ltd Profitability Ratios (%)

Metropolis Healthcare Ltd Liquidity Ratios

Metropolis Healthcare Ltd Liquidity Ratios (%)

Metropolis Healthcare Ltd Interest Coverage Ratios (%)

Metropolis Healthcare Ltd Valuation Ratios

Fair Value of Metropolis Healthcare Ltd Stock

Fair Value: ₹2180.98

The stock is undervalued by 27.99% compared to the current price ₹1704

*Investments are subject to market risks

Strength and Weakness of Metropolis Healthcare Ltd Stock

  1. The stock has a high average ROCE of 31.60%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 14.80, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -8.70, which is a positive sign.
  4. The company has higher reserves (558.09 cr) compared to borrowings (101.27 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (466.27 cr) and profit (173.27 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 45.35 and average Dividend Yield of 23.29%.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Metropolis Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE